IL10 and colorectal carcinoma: From a mechanistic perspective, PKN2 inhibited the expression of IL-4 and IL-10 in CRC cells by suppressing dual specificity phosphatase 6/extracellular signal-regulated kinase 1/2 (DUSP6/ERK1/2) signaling [109].